Medical/Pharmaceuticals

PerfectPrime Unleashes World's First Handheld Thermal Camera For Fever Detection With Top Accuracy

HONG KONG, July 17, 2020 /PRNewswire/ -- The world is facing a never before seen crisis which has cost economies billions of dollars and affected an unprecedented number of lives. The coronavirus has forced people to stay home and out of work at its peak but businesses are now slowly opening up a...

2020-07-17 10:00 3181

VectraCor and GS GmbH (Corpuls) Form Licensing Agreement to Incorporate VectraCor's 22-Lead ECG and CEB® (Cardiac Electrical Biomarker) Technology in Corpuls Defibrillators

Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 17, 2020 /PRNewswire/ -- GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today t...

2020-07-17 04:47 3642

MindBeauty Launches Upgraded AA99 Reusable Face Mask that is Certified to Work Against Coronavirus

HONG KONG, July 16, 2020 /PRNewswire/ -- Since the launch of the original AA99® Reusable Face Mask in March 2020, MindBeauty has been working with consumers and technical experts to modify its mask in line with current global healthcare needs and is proud to announce, to the best oftheir knowledg...

2020-07-16 19:09 4501

New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs

* Xpert® MTB/XDR cartridge enables expanded drug-resistance profiling in less than 90 minutes * Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), the test could help fill a critical gap that is cu...

2020-07-16 19:00 12985

Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, July 16, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company, today announced that the Company presented preclinical data from a fully human CD73 antibody (HBM1007) in an e-poster at the American...

2020-07-16 18:00 4281

PerfectPrime Unleashes World's First Handheld Thermal Camera For Fever Detection with Top Accuracy

HONG KONG, July 16, 2020 /PRNewswire/ -- The world is facing a never before seen crisis which has cost economies billions of dollars and affected an unprecedented number of lives. The coronavirus has forced people to stay home and out of work at its peak but businesses are now slowly opening up a...

2020-07-16 17:00 1469

Getinge Interim Report January-June 2020: Making a Real Difference Together With our Customers

GOTHENBURG, Sweden, July 16, 2020 /PRNewswire/ -- "During this year's second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry," says Mattias Perjos, Pr...

2020-07-16 14:19 9810

Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Waldenström Macroglobulinemia

SUZHOU, China and ROCKVILLE, Md., July 15, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...

2020-07-15 21:07 2322

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

TOKYO and DEVENTER, Netherlands, July 15, 2020 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., aNetherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radia...

2020-07-15 14:05 18504

Mexico Telecommunication Giant, Alestra, Deploys Bright Pattern Contact Center Software for CENACED's Telehealth Services During COVID-19

Alestra, deploys Bright Pattern Contact Center for nonprofit, CENACED, to offer remote psychological teleassistance services during the pandemic SOUTH SAN FRANCISCO, California, July 15, 2020 /PRNewswire/ -- CENACED, a non-profit healthcare organization, has deployed Bright Pattern as their clou...

2020-07-15 02:30 2197

University of Toronto Tests Confirm First Mask That Deactivates Coronavirus

MIRABEL, Quebec, July 14, 2020 /PRNewswire/ -- i3 BioMedical Inc. today announced that a team of scientists at theUniversity of Toronto tested and established that the virus SARS-CoV-2, which causes Covid-19, cannot be recovered after being applied to the TrioMed Active mask. The mask's external ...

2020-07-14 20:25 5230

UL Helps Advance Vaccination Storage Technologies with New World Health Organization Accreditation

With an anticipated surge in the need for vaccine storage in preparation for COVID-19 vaccination release, World Health Organization accredited testing will help refrigeration OEMs ensure refrigeration reliability and temperature consistency impacting overall vaccine efficacy. BENGALURU, India, ...

2020-07-14 20:00 3160

Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China

HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (stock code: 2500.HK), the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating...

2020-07-14 18:19 19126

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia

SAN DIEGO and SAFFRON WALDEN, United Kingdom, July 14, 2020 /PRNewswire/ -- Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise ...

2020-07-14 18:00 2871

Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies With Precision-Targeted T-Cell Engaging Antibodies

- Novel antibody-based cancer immunotherapies to be developed through combining Revitope's dual-antigen precision T-cell engager platform (TEAC) and Junshi Biosciences' antibodies - Revitope to design up to 5 TEAC molecules against tumor targets selected by Junshi Biosciences - For each TEAC mo...

2020-07-14 09:01 6552

Zuellig Pharma appoints John Graham as new CEO

SINGAPORE, July 14, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider inAsia, announces the appointment of John Graham as its new CEO. John will run theUS$13 billion business and lead the team across 13 markets inAsia.

2020-07-14 09:00 9568

Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

Five technologies empowering preclinical disease modeling are providing preclinical research with highly accurate and precise services SANTA CLARA, California, July 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advances Facilitating Research across Preclinical Disease...

2020-07-14 01:55 1536

Vela Diagnostics receives CE-IVD approval and Provisional Authorisation from the Health Sciences Authority in Singapore for automated COVID-19 detection test

SINGAPORE, July 13, 2020 /PRNewswire/ -- Vela Diagnostics announced today that an automated version of its COVID-19 detection test, the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0, has received the CE mark forin vitro diagnostic use as well as Provisional Authorisation from the Health Sciences Authority...

2020-07-13 17:37 1778

PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19

FLORENCE, Italy, July 13, 2020 /PRNewswire/ -- With the pandemic caused by COVID-19, the continuous need to obtain information has pushed people to rely on unreliable sources, thus fomenting thespread of fake news. For this reason Gilda D'Incerti, CEO and founder of PQE Group

2020-07-13 16:00 2743

AVATAMED Partners CBmed in Europe on Precision Cancer Project

SINGAPORE, July 13, 2020 /PRNewswire/ -- AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, leveraging on a new technology in cancer research. The Medical Universities ofGraz and Vienna and the HEALTH Institute of Joanneum Researc...

2020-07-13 15:16 2913
1 ... 364365366367368369370 ... 399

Week's Top Stories